MuRF1-IN-1
MuRF1-IN-1 is an orally active MuRF1 inhibitor. MuRF1-IN-1 can inhibit the interaction between MuRF1 and titin as well as E3 ligase activity. MuRF1-IN-1 can alleviate skeletal muscle atrophy and dysfunction in cardiac cachexia[1].
Product Specifications
CAS Number
445222-91-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/murf1-in-1.html
Purity
98.16
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
N#CC1=C(N)OC(CCCC2=O)=C2C13C(N(C)C4=C3C=CC=C4)=O
Molecular Formula
C18H15N3O3
Molecular Weight
321.33
Precautions
H302, H315, H319, H335
References & Citations
[1]Bowen TS, Adams V, Werner S, et al. Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia. J Cachexia Sarcopenia Muscle. 2017 Dec;8 (6) :939-953.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY430303 100 µg
P2X2 (P2RX2) (NM_170683) Human Over-expression Lysate
Sign In for Pricing
View Details